Cargando…

Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study

BACKGROUND: Incidence of acute rheumatic fever (ARF) and prevalence of rheumatic heart disease (RHD) in the Pacific region, including New Caledonia, are amongst the highest in the world. The main priority of long-term management of ARF or RHD is to ensure secondary prophylaxis is adhered to. The obj...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasse, Brunelle, Baroux, Noémie, Rouchon, Bernard, Meunier, Jean-Michel, Frémicourt, Isabelle De, D’Ortenzio, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626837/
https://www.ncbi.nlm.nih.gov/pubmed/23402561
http://dx.doi.org/10.1186/1471-2458-13-131
_version_ 1782266252797935616
author Gasse, Brunelle
Baroux, Noémie
Rouchon, Bernard
Meunier, Jean-Michel
Frémicourt, Isabelle De
D’Ortenzio, Eric
author_facet Gasse, Brunelle
Baroux, Noémie
Rouchon, Bernard
Meunier, Jean-Michel
Frémicourt, Isabelle De
D’Ortenzio, Eric
author_sort Gasse, Brunelle
collection PubMed
description BACKGROUND: Incidence of acute rheumatic fever (ARF) and prevalence of rheumatic heart disease (RHD) in the Pacific region, including New Caledonia, are amongst the highest in the world. The main priority of long-term management of ARF or RHD is to ensure secondary prophylaxis is adhered to. The objectives of this study were to evaluate rates of adherence in people receiving antibiotic prophylaxis by intramuscular injections of penicillin in Lifou and to determine the factors associated with a poor adherence in this population. METHODS: We conducted a retrospective cohort study and we included 70 patients receiving injections of antibiotic prophylaxis to prevent ARF recurrence on the island of Lifou. Patients were classified as “good-adherent” when the rate of adherence was ≥80% of the expected injections and as “poor-adherent” when it was <80%. Statistical analysis to identify factors associated with adherence was performed using a multivariate logistic regression model. RESULTS: Our study showed that 46% of patients from Lifou receiving antibiotic prophylaxis for ARF or RHD had a rate of adherence <80% and were therefore at high risk of recurrence of ARF. Three independent factors were protective against poor adherence: a household with more than five people (odds ratio, 0.25; 95% confidence interval [CI], 0.08 to 0.75), a previous medical history of symptomatic ARF (odds ratio, 0.20; 95% CI, 0.04 to 0.98) and an adequate healthcare coverage (odds ratio, 0.21; 95% CI 0.06 to 0.72). CONCLUSIONS: To improve adherence to secondary prophylaxis in Lifou, we therefore propose the following recommendations arising from the results of this study: i) identifying patients receiving antibiotic prophylaxis without medical history of ARF to strengthen their therapeutic education and ii) improving the medical coverage in patients with ARF or RHD. We also recommend that the nurse designated for the ARF prevention program in Lifou coordinate an active recall system based on an updated local register. But the key point to improve adherence among Melanesian patients is probably to give appropriate information regarding the disease and the treatment, taking into account the Melanesian perceptions of the disease.
format Online
Article
Text
id pubmed-3626837
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36268372013-04-16 Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study Gasse, Brunelle Baroux, Noémie Rouchon, Bernard Meunier, Jean-Michel Frémicourt, Isabelle De D’Ortenzio, Eric BMC Public Health Research Article BACKGROUND: Incidence of acute rheumatic fever (ARF) and prevalence of rheumatic heart disease (RHD) in the Pacific region, including New Caledonia, are amongst the highest in the world. The main priority of long-term management of ARF or RHD is to ensure secondary prophylaxis is adhered to. The objectives of this study were to evaluate rates of adherence in people receiving antibiotic prophylaxis by intramuscular injections of penicillin in Lifou and to determine the factors associated with a poor adherence in this population. METHODS: We conducted a retrospective cohort study and we included 70 patients receiving injections of antibiotic prophylaxis to prevent ARF recurrence on the island of Lifou. Patients were classified as “good-adherent” when the rate of adherence was ≥80% of the expected injections and as “poor-adherent” when it was <80%. Statistical analysis to identify factors associated with adherence was performed using a multivariate logistic regression model. RESULTS: Our study showed that 46% of patients from Lifou receiving antibiotic prophylaxis for ARF or RHD had a rate of adherence <80% and were therefore at high risk of recurrence of ARF. Three independent factors were protective against poor adherence: a household with more than five people (odds ratio, 0.25; 95% confidence interval [CI], 0.08 to 0.75), a previous medical history of symptomatic ARF (odds ratio, 0.20; 95% CI, 0.04 to 0.98) and an adequate healthcare coverage (odds ratio, 0.21; 95% CI 0.06 to 0.72). CONCLUSIONS: To improve adherence to secondary prophylaxis in Lifou, we therefore propose the following recommendations arising from the results of this study: i) identifying patients receiving antibiotic prophylaxis without medical history of ARF to strengthen their therapeutic education and ii) improving the medical coverage in patients with ARF or RHD. We also recommend that the nurse designated for the ARF prevention program in Lifou coordinate an active recall system based on an updated local register. But the key point to improve adherence among Melanesian patients is probably to give appropriate information regarding the disease and the treatment, taking into account the Melanesian perceptions of the disease. BioMed Central 2013-02-12 /pmc/articles/PMC3626837/ /pubmed/23402561 http://dx.doi.org/10.1186/1471-2458-13-131 Text en Copyright © 2013 Gasse et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gasse, Brunelle
Baroux, Noémie
Rouchon, Bernard
Meunier, Jean-Michel
Frémicourt, Isabelle De
D’Ortenzio, Eric
Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
title Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
title_full Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
title_fullStr Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
title_full_unstemmed Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
title_short Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
title_sort determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on lifou, new caledonia: a retrospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626837/
https://www.ncbi.nlm.nih.gov/pubmed/23402561
http://dx.doi.org/10.1186/1471-2458-13-131
work_keys_str_mv AT gassebrunelle determinantsofpooradherencetosecondaryantibioticprophylaxisforrheumaticfeverrecurrenceonlifounewcaledoniaaretrospectivecohortstudy
AT barouxnoemie determinantsofpooradherencetosecondaryantibioticprophylaxisforrheumaticfeverrecurrenceonlifounewcaledoniaaretrospectivecohortstudy
AT rouchonbernard determinantsofpooradherencetosecondaryantibioticprophylaxisforrheumaticfeverrecurrenceonlifounewcaledoniaaretrospectivecohortstudy
AT meunierjeanmichel determinantsofpooradherencetosecondaryantibioticprophylaxisforrheumaticfeverrecurrenceonlifounewcaledoniaaretrospectivecohortstudy
AT fremicourtisabellede determinantsofpooradherencetosecondaryantibioticprophylaxisforrheumaticfeverrecurrenceonlifounewcaledoniaaretrospectivecohortstudy
AT dortenzioeric determinantsofpooradherencetosecondaryantibioticprophylaxisforrheumaticfeverrecurrenceonlifounewcaledoniaaretrospectivecohortstudy